Donafenib Monotherapy for Previously Treated Metastatic Gastric Cancer

NCT02489214 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

13

Enrollment

INDUSTRY

Sponsor class

Stopped Corporate policy adjustments

Conditions

Gastric Cancer

Interventions

DRUG: donafenib tosilate tablets

Sponsor

Suzhou Zelgen Biopharmaceuticals Co.,Ltd